- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Lawsuits and the sluggish economy continue to affect the healthcare industry significantly this year. Here is a look at two companies dealing with those drivers:
Bristol-Myers Squibb (NYSE:BMY): Current Price $34.30
After one patient died from liver disease and several others were hospitalized during a trial for the company’s hepatitis C treatment last August, four trial subjects filed personal injury claims against Bristol-Myers Squibb and 10 more are preparing to file. Even though the pharmaceutical manufacturer halted the study immediately and took a $1.8 billion charge that quarter, the company now faces requests for medical costs and damages that surpass $500 million.
Bristol-Myers Squibb is scheduled to begin discussing claims settlements on Wednesday, according to The Wall Street Journal.
In addition to the financial strains the botched trial brought, the company suffered a setback in its drug pipeline and Bristol will have to start its efforts to enter the $5 billion global market for hepatitis C treatments anew. The often-fatal liver disease is the leading cause of liver transplants in the United States, where approximately 3.2 million people suffer from the affliction…
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.